VCEL Vericel Corporation

Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: -0- *T What: Aastrom Biosciences Fourth Quarter and Fiscal Year End FY2005 Investor Conference Call When: Thursday, September 8, 2005 @ 11:00 AM Eastern Where: http://www.vcall.com/EventPage.asp?ID=94806 How: Live over the Internet -- Simply log on to the web at the address above. Interested parties should call toll-free (877) 407-9205, or from outside the U.S. (201) 689-8054. Contact: Investor Relations Department, (734) 930-5777 or mail@aastrom.com *T If you are unable to participate during the live webcast, the call will be available for replay at http://www.vcall.com/ClientPage.asp?ID=94806 or http://www.investorcalendar.com/ Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing patient-specific products for the repair or regeneration of human tissues, utilizing the Company's proprietary adult stem cell technology. Aastrom's strategic position in the tissue regeneration sector is enabled by its proprietary Tissue Repair Cells (TRCs), a mix of bone marrow-derived adult stem and progenitor cells, and the AastromReplicell(R) System, an industry-unique automated cell production platform used to produce cells for clinical use. TRCs are the core component of the products Aastrom is developing for severe bone fractures, ischemic vascular disease, jaw reconstruction and spine fusion, with Phase I/II level clinical trials active in the U.S. and EU for some of these indications. For more information, visit Aastrom's website at www.aastrom.com.